Link Cell Therapies initiates clinical dosing, upsizes Series A financing to $90 million
The company also said it expanded executive leadership.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Link Cell Therapies Initiates Clinical Dosing With Logic-Gated Car-T Therapy, Expands Executive Leadership, And Upsizes Series A Financing To $90 Million
Link Cell Therapies Initiates Clinical Dosing With Logic-Gated Car-T Therapy, Expands Executive Leadership, And Upsizes Series A Financing To $90 Million